ESUR guideline: gadolinium-based contrast media and nephrogenic systemic fibrosis

ISSN： 0938-7994

Source： European Radiology, Vol.17, Iss.10, 2007-10, pp. : 2692-2696

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Iodine contrast media doses equal-attenuating with gadolinium chelates at CT-aortography may have less risk of contrast-induced nephropathy and no risk of nephrogenic systemic fibrosis in azotaemic patients!

By Nyman Ulf

European Radiology, Vol. 18, Iss. 9, 2008-09 ,pp. : 2013-2014

Springer Publishing Company

Access to resources Recommend Favorite

Effects of Gadolinium Contrast Agents in Naive and Nephrectomized Rats: Relevance to Nephrogenic Systemic Fibrosis

By Grant D. Johnsen H. Juelsrud A. Løvhaug D.

Acta Radiologica, Vol. 50, Iss. 2, 2009-01 ,pp. : 156-169

Blackwell Publishing

Access to resources Recommend Favorite

Gadolinium-based contrast media may be nephrotoxic even at approved doses

By Thomsen Henrik

European Radiology, Vol. 14, Iss. 9, 2004-09 ,pp. : 1654-1656

Springer Publishing Company

Access to resources Recommend Favorite

Nephrogenic Systemic Fibrosis: Experimental Studies Confound Prevailing Theory of Free Gadolinium as a Causative Factor

By Jakobsen J.

Acta Radiologica, Vol. 49, Iss. 6, 2008-01 ,pp. : 616-617

Blackwell Publishing

Access to resources Recommend Favorite

Enhanced Computed Tomography or Magnetic Resonance Imaging: A Choice between Contrast Medium-Induced Nephropathy and Nephrogenic Systemic Fibrosis?

By Thomsen H. S. Marckmann P. Logager V. B.

Acta Radiologica, Vol. 48, Iss. 6, 2007-01 ,pp. : 593-596

Blackwell Publishing

Access to resources Recommend Favorite